• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers.影响小儿分化型甲状腺癌颈淋巴结转移的因素
Indian J Surg Oncol. 2022 Mar;13(1):92-98. doi: 10.1007/s13193-021-01312-w. Epub 2021 Mar 25.
2
Differentiated Thyroid Cancer in a Pediatric Population: Estimating the Risk of Recurrence and Evolution Over Time.儿童人群中的分化型甲状腺癌:评估复发风险及随时间的演变情况
Cureus. 2023 Jan 28;15(1):e34313. doi: 10.7759/cureus.34313. eCollection 2023 Jan.
3
Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?分化型甲状腺癌患儿的风险分层:任何风险患者都需要行甲状腺全切除术吗?
Thyroid. 2020 Apr;30(4):548-556. doi: 10.1089/thy.2019.0231. Epub 2020 Mar 11.
4
Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer.局部晚期分化型甲状腺癌术后残留淋巴结转移的部位和原因。
Thyroid. 2018 May;28(5):593-600. doi: 10.1089/thy.2017.0434. Epub 2018 Apr 23.
5
Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.基于淋巴结转移的儿童及青少年分化型甲状腺癌实用初始危险分层。
Thyroid. 2018 Feb;28(2):193-200. doi: 10.1089/thy.2017.0214. Epub 2018 Jan 3.
6
The clinical impact of extrathyroidal extensions on prognoses in pediatric differentiated thyroid cancers.甲状腺外延伸对儿童分化型甲状腺癌预后的临床影响。
J Pediatr Surg. 2022 Aug;57(8):1532-1537. doi: 10.1016/j.jpedsurg.2021.09.035. Epub 2021 Sep 25.
7
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
8
Role and Extent of Neck Dissection for Neck Lymph Node Metastases in Differentiated Thyroid Cancers.分化型甲状腺癌颈部淋巴结转移的颈部清扫术的作用及范围
Sisli Etfal Hastan Tip Bul. 2021 Dec 29;55(4):438-449. doi: 10.14744/SEMB.2021.76836. eCollection 2021.
9
Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification.甲状腺乳头状微小癌的术前和术后风险分层:熊本标准与 2015 年美国甲状腺协会指南风险分层的比较研究。
Thyroid. 2020 Jun;30(6):857-862. doi: 10.1089/thy.2019.0698. Epub 2020 Mar 11.
10
Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.儿童分化型甲状腺癌早期和长期缓解的预后因素:性别、年龄、临床表现及新提出的美国甲状腺协会风险分层系统的作用
Thyroid. 2016 Oct;26(10):1480-1487. doi: 10.1089/thy.2016.0302. Epub 2016 Sep 22.

引用本文的文献

1
The predictive value of thyroid hormone sensitivity parameters for cervical lymph node metastasis in patients with differentiated thyroid cancer.甲状腺激素敏感性参数对分化型甲状腺癌患者颈部淋巴结转移的预测价值。
Ann Med. 2025 Dec;57(1):2443564. doi: 10.1080/07853890.2024.2443564. Epub 2024 Dec 27.

本文引用的文献

1
Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.甲状腺外侵犯是儿童分化型甲状腺癌区域淋巴结转移的重要预测因素。
Thyroid. 2020 Jul;30(7):1037-1043. doi: 10.1089/thy.2019.0229. Epub 2019 Oct 1.
2
Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.儿童和青少年甲状腺乳头状癌中央区和侧方区颈部淋巴结转移的预测因素
World J Surg. 2018 Aug;42(8):2444-2453. doi: 10.1007/s00268-018-4487-z.
3
Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.基于淋巴结转移的儿童及青少年分化型甲状腺癌实用初始危险分层。
Thyroid. 2018 Feb;28(2):193-200. doi: 10.1089/thy.2017.0214. Epub 2018 Jan 3.
4
The 2017 Bethesda System for Reporting Thyroid Cytopathology.2017 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
5
Predictors of nodal metastasis in pediatric differentiated thyroid cancer.儿童分化型甲状腺癌淋巴结转移的预测因素
J Pediatr Surg. 2017 Jan;52(1):120-123. doi: 10.1016/j.jpedsurg.2016.10.033. Epub 2016 Oct 27.
6
Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.分化型甲状腺癌患儿的初始和动态风险分层
J Clin Endocrinol Metab. 2017 Mar 1;102(3):793-800. doi: 10.1210/jc.2016-2666.
7
Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma.甲状腺外扩展范围作为甲状腺乳头状癌患者淋巴结转移和结外扩展的重要预测指标
Ann Surg Oncol. 2017 Feb;24(2):460-468. doi: 10.1245/s10434-016-5594-4. Epub 2016 Sep 21.
8
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.儿童甲状腺结节和分化型甲状腺癌管理指南
Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460.
9
Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up.(131)I 治疗后不完全缓解的儿童甲状腺乳头状癌肺转移患者疾病的良好转归:10 年随访。
Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):651-5. doi: 10.1007/s00259-010-1669-9. Epub 2010 Nov 27.
10
Treatment strategy of papillary thyroid carcinoma in children and adolescents: clinical significance of the initial nodal manifestation.儿童和青少年甲状腺乳头状癌的治疗策略:初始淋巴结表现的临床意义。
Ann Surg Oncol. 2009 Dec;16(12):3442-9. doi: 10.1245/s10434-009-0673-4. Epub 2009 Sep 24.

影响小儿分化型甲状腺癌颈淋巴结转移的因素

Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers.

作者信息

Qureshi Sajid S, Kazi Mufaddal, Noronha Jarin, Smriti Vasundhara, Basu Sandeep, Shah Sneha, Talole Sanjay

机构信息

Division of Paediatric Surgical Oncology, Department of Surgical Oncology, Tata Memorial Hospital and Advanced Centre for Training Research and Education in Cancer (ACTREC), Tata Memorial Centre, Ernest Borges Road, Parel, Mumbai, 400012 India.

Homi Bhabha National Institute (HBNI), Mumbai, India.

出版信息

Indian J Surg Oncol. 2022 Mar;13(1):92-98. doi: 10.1007/s13193-021-01312-w. Epub 2021 Mar 25.

DOI:10.1007/s13193-021-01312-w
PMID:35462647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8986908/
Abstract

Lymph node metastasis is a considerable variable influencing postoperative American Thyroid Association (ATA) risk stratification in pediatric differentiated thyroid cancer (DTC). The primary aim of this study was to ascertain the factors predicting nodal metastasis and describe the outcomes in relation to the ATA risk. Patients 18 years or younger operated between December 2005 and December 2019 were analyzed. Demographic, clinicopathological, treatment, and outcome data were recorded. Factors associated with nodal metastasis were assessed by univariate and multivariate regression analysis. Patients were stratified into low-, intermediate-, and high-risk as per the pediatric ATA guidelines. A total of 86 patients (43% male; median [IQR] age, 12 (10-14) years) underwent surgery during the study period. Lymph node metastases were present in 70 (82.4%) patients involving the lateral (8%) and central compartment (4.7%) alone and both (88.6%) compartments. Extrathyroid extension (ETE) was present in 65%; 35%, minimal; and 30%, extensive. On univariate analysis, nodal metastasis was more frequent in male patients, multifocal tumor, lymphovascular invasion, and ETE. On multivariate analysis, only ETE was predictive of nodal disease with an odds ratio of 8. Minimal and extensive ETEs were both significantly associated with lymph node metastases when compared to the absence of ETE. The 5-year disease-free survival was 100%, 95.7%, and 66% in the low-, intermediate-, and high-risk groups respectively ( < 0.0001). Pediatric DTCs have an exceptionally high incidence of lymph node metastasis. ETE is the single most important predictor of nodal disease. The ATA pediatric risk stratification is useful in predicting clinical outcomes.

摘要

淋巴结转移是影响儿童分化型甲状腺癌(DTC)术后美国甲状腺协会(ATA)风险分层的一个重要变量。本研究的主要目的是确定预测淋巴结转移的因素,并描述与ATA风险相关的结果。对2005年12月至2019年12月期间接受手术的18岁及以下患者进行分析。记录人口统计学、临床病理、治疗和结果数据。通过单因素和多因素回归分析评估与淋巴结转移相关的因素。根据儿科ATA指南,将患者分为低、中、高风险组。在研究期间,共有86例患者(43%为男性;中位[IQR]年龄为12(10 - 14)岁)接受了手术。70例(82.4%)患者存在淋巴结转移,仅累及侧方(8%)和中央区(4.7%)以及两者均累及(88.6%)。65%的患者存在甲状腺外侵犯(ETE);35%为轻度;30%为广泛侵犯。单因素分析显示,男性患者、多灶性肿瘤、淋巴管侵犯和ETE中淋巴结转移更为常见。多因素分析显示,只有ETE可预测淋巴结疾病,比值比为8。与无ETE相比,轻度和广泛ETE均与淋巴结转移显著相关。低、中、高风险组的5年无病生存率分别为100%、95.7%和66%(<0.0001)。儿童DTC的淋巴结转移发生率异常高。ETE是淋巴结疾病的唯一最重要预测因素。ATA儿科风险分层有助于预测临床结果。